Access at: www. ECRjournal.com Up to 50% of patients who undergo elective coronary angiography for stable chest pain symptoms that are mainly related to exercise and typical enough to suggest the presence of obstructive coronary artery disease (CAD) are found to have normal or near-normal coronary arteries. 1 The mechanisms responsible for angina chest pain in these patients are heterogeneous; accordingly, their identification is crucial for the tailored management of individual patients.
The Diagnosis of Microvascular Angina
Since small coronary arteries cannot be assessed at angiography, in clinical practice the diagnosis of MVA is usually hypothesised after the exclusion of other possible causes of symptoms, both cardiac and non-cardiac. Cardiac causes include both ischaemic (e.g. epicardial spasm; see later) and non-ischaemic diseases (e.g. inflammatory diseases, abnormal stimulation of cardiac nociceptors), 4 whereas non-cardiac causes include gastro-oesophageal disorders, in particular gastro-oesophageal reflux, 5 as well as musculoskeletal and psychosomatic causes.
However, a definitive diagnosis of MVA requires the documentation of functional abnormalities of the coronary microcirculation.
Methods to Assess Coronary Microvascular Function
Several methods have been proposed to assess coronary microvascular function. 6, 7 Independent of the method applied, the assessment of the functional state of coronary microcirculation is based on the measurement of CBF and/or CVR at rest and following the administration of vasoactive stimuli, with the effect expressed as the ratio of peak-to-basal values or the percent of variation.
Invasive methods are considered the gold standard to measure the response to vasoactive stimuli of the coronary microcirculation. CBF has classically been derived from CBF velocity measured by intracoronary Doppler wires. 8 More recently, an intracoronary thermodilution-derived method has been introduced to measure CBF using a wire that also allows the simultaneous measurement of intracoronary pressure and the calculation of an index of coronary microvascular resistance.
In some studies, this method has been found to achieve more reproducible results. 9 However, recent data have shown a better correlation of Doppler-derived measurements of coronary flow reserve (CFR) compared with thermodilution-derived measurements, with CFR assessed by non-invasive methods, such as PET and cardiac MRI (CMR;
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see later) suggesting that they show more reliable results on coronary microvascular function. 10, 11 Invasive methods, however, present with some limitations, including the prolongation of diagnostic angiography and an increase in cost and risk.
In the absence of obstructive CAD, coronary microvascular dilator function can reliably be investigated by several non-invasive methods that allow measurement of CBF.
Cardiac PET is perhaps the most reliable method at present, and has been applied in several studies in patients with suspected MVA. 12, 13 PET allows quantitative measurements of myocardial blood flow (MBF; both global and regional) using myocardial distribution and radioactivity of tracers such as 15 O-water, 13 N-ammonia, and 82 rubidium. 6, 7, 10 CMR also allows for reliable assessment of coronary microvascular function in patients with angina and normal/near-normal coronary arteries, using the paramagnetic contrast medium gadolinium to measure MBF. 11, 14, 15 Compared with PET, CMR has the advantage of being radiation free and having a higher spatial resolution; however, post-acquisition processing is more complicated, artefacts are more frequent, and gadolinium should be avoided in patients with renal failure. 6, 7 The use of PET and CMR to routinely assess coronary microvascular function in clinical practice is mainly challenged by limited availability and high costs.
Myocardial contrast echocardiography is an attractive method used to assess coronary microvascular function, as it is based on using gas-filled microbubbles as echo-contrast, a largely available and inexpensive echocardiographic technique used to measure MBF.
Although found to be reliable in some studies, its diffusion has been restrained by some limitations, including operator dependence, difficulty in obtaining reliable images in some conditions (e.g. obesity, pulmonary disease), and some unresolved technical issues. 6, 7, 16, 17 In some studies on patients with suspected MVA, coronary microvascular function has been assessed using transthoracic Doppler echocardiography. 17, 18 In this method, blood flow in the mid-part of the left anterior descending coronary artery is imaged by colourDoppler using a high-frequency ultrasound probe (7-10 MHz) and CBF velocity is measured by the pulsed Doppler technique. Transthoracic Doppler echocardiography is a potentially largely applicable method as it is easily available and inexpensive. 19 Limitations include operator dependence and the inability to obtain good echocardiographic windows in some patients. 6 
Assessment of Coronary Microvascular Dilatation
Since chest pain in patients with a suspected stable MVA is mainly induced by physical efforts, it seems reasonable to investigate whether an impairment of dilatation of resistance coronary arteries, limiting the increase of CBF required to match the enhanced myocardial oxygen requirements, is present.
CBF is regulated at the microvascular level by multiple mechanisms, including metabolic, neural, humoral, and mechanical (shear stress)
factors. 20 When required, coronary microvascular dilatation can be achieved by using various substances to induce a direct relaxant effect on the smooth muscle cells (SMCs) of resistance arteries. Other stimuli, however, result in microvascular dilatation indirectly by inducing the release of dilator substances from the endothelium (mainly nitric oxide
[NO]) that eventually act on SMCs. Thus, an impairment of maximal dilatation of the coronary microcirculation may result from either a reduced response of SMCs to dilator stimuli, impaired production and/ or release of dilator substances by the endothelium (endotheliumdependent dilatation), or both. 5 In typical patients with a suspicion of MVA, an assessment of CBF response to exercise would be ideal to assess coronary microvascular dilatation. However, the measurement of CBF during maximal exercise presents practical issues, both with invasive and non-invasive methods.
Atrial pacing might be an alternative stimulus to assess CBF response to increased myocardial oxygen consumption, but it also presents with practical issues. Thus, coronary microvascular dilatation is usually assessed by measuring CBF in response to dilator pharmacologic substances.
Endothelium-independent Coronary Microvascular Dilatation
Although various substances (e.g. papaverine, dobutamine, organic nitrates) have been used to investigate the intrinsic dilator capacity of the coronary microcirculation, the arteriolar dilator adenosine and its agonists, dipyridamole and (more recently) regadenoson, are used most frequently ( Table 1) . [21] [22] [23] A CFR (ratio between CBF at peak drug administration and at baseline) <2.0 definitively identifies coronary microvascular dysfunction (CMD), whereas an increase in CBF between >2.0 and <2.5 is of borderline significance.
It should be underscored that impaired dilatation of small coronary arteries might originate from functional abnormalities, structural alterations (e.g. SMC hypertrophy, medial fibrosis, intimal thickening), or both.
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Endothelium-dependent Coronary Microvascular Dilatation
Endothelium-dependent coronary microvascular dilatation is usually assessed invasively using an acetylcholine test ( Table 1) . In normal subjects, intracoronary acetylcholine at low-medium doses (usually 10-50 µg) causes microvascular dilatation through the release of NO by endothelial cells, 26 with a mild dilator effect also seen on epicardial vessels.
In patients with endothelial dysfunction, the release of NO induced by acetylcholine is impaired, thus resulting in lower degrees of dilatation of small coronary arteries, as indicated by a lower increase in CBF and/or reduction in CVR. Moreover, in case of severe endothelial dysfunction, acetylcholine may actually cause microvascular constriction, as documented by a reduction in CBF and/ or increase in CVR. 27, 28 Through stimulation of muscarinic receptors, acetylcholine also exerts a direct vasoconstrictor effect on SMCs that in normal subjects is masked by the prevailing endotheliummediated dilatation, but which may become apparent in case of severe endothelial dysfunction. 29 There is no clear definition of impaired endothelium-dependent coronary microvascular dilatation with the acetylcholine test, but it has been suggested that failure to increase CBF by >50% should be considered indicative of an impaired dilator response of the coronary microcirculation.
30,31
Diagnostic for Stable Angina and No Obstructive Coronary Arteries
Coronary microvascular endothelial function has also been assessed using other stimuli, in particular the cold pressor test (CPT), which comprises placing a hand in ice for 90 to 120 seconds. The sensation of cold and the accompanying hand pain cause a mild sympathetic activation that slightly increases heart rate and blood pressure; the resulting mild increase in myocardial oxygen consumption determines arteriolar dilation and flow-mediated (endothelium-dependent) dilatation of pre-arteriolar vessels. Furthermore, NO release may also result from the stimulation of endothelial alpha-adrenergic receptors. 32 Normal values of CBF response to the CPT have also not been well defined, but we have found that a CBF velocity increase on transthoracic Doppler echocardiography >1.56 allowed a clear discrimination between healthy subjects and MVA patients. 17 
Microvascular Versus Epicardial Spasm
Some studies have suggested that, at least in some patients, stable MVA might be related to increased coronary microvascular constriction/ spasm rather than impaired dilatation. A significant reduction in CBF or increase in CVR has been shown in response to potentially constrictive stimuli, including acetylcholine, hyperventilation, and mental stress, in the absence of any flow-limiting epicardial constriction. 27, 28, 33 Importantly, some studies have recently shown that a sizeable proportion of patients with a suspicion of stable MVA develop typical angina and ischaemic electrocardiographic (ECG) changes in the absence of any significant epicardial spasm in response to higher doses of acetylcholine (up to 200 µg), indicating the induction of coronary microvascular spasm. [34] [35] [36] Accordingly, it has been suggested that the identification of microvascular spasm as a mechanism of angina symptoms should be achieved by this method rather than by CBF/CVR measurements. 37 Importantly, the same doses of acetylcholine have been shown to trigger epicardial spasm in more than 60% of patients, suggesting that this mechanism -rather than microvascular spasm -could be a cause of angina symptoms in a subgroup of patients. 34-36 ,8 Of note, the fact that both coronary microvascular and epicardial spasm have been described in patients with stable angina but no obstructive CAD makes it necessary to perform vasoconstrictive tests during invasive coronary angiography to establish the site of the spasm. The tendency towards coronary spasm might also be assessed non-invasively (e.g. by ergonovine test; In a 2011 study, we found an impairment of coronary microvascular dilatation to both adenosine and CPT in 44% of 71 patients with a suspicion of MVA, whereas 21% and 10% of patients presented with an impairment of coronary microvascular dilatation in response to either adenosine or CPT, respectively. 17 In a study by Sara et al., an abnormal coronary microvascular response to both adenosine and acetylcholine was found in 36.1% of 1,439 patients, whereas a discordant response was found in 45.2% of patients. 41 Finally, in the recently published CORonary MICrovascular Angina (CorMicA) trial, 20.5% of patients had evidence of both impaired response to adenosine and a positive acetylcholine test, while epicardial spasm was induced in 16.5% and CMD (either impaired dilatation or microvascular spasm) in 51.6% of 151 patients. 36 Thus, a complete characterisation of CMD and functional abnormalities of coronary circulation in individual patients requires assessment of all the types of tests described above, which might have implications on the choice of specific or combined forms of treatment.
Limitations in the Interpretation of Provocative Tests
We should be aware that, in contrast to current beliefs, there are significant pitfalls in the interpretation of provocative coronary tests and, therefore, the accurate characterisation of coronary alterations.
Thus, the stimuli used to assess endothelium-dependent dilatation are not specific to these tests. Acetylcholine, as discussed above, has also vasoconstrictor effects, and it is not possible to exclude that this effect contributes to the abnormal coronary microvascular response detected by its administration in MVA patients, possibly resulting from an increased reactivity of SMCs. Similar considerations apply to other endothelium-dependent dilator stimuli, such as the CPT, which might trigger spasm in hyperreactive coronary segments through adrenergic activation. 42 It should be also observed that, in the presence of a global impairment of SMC relaxation in response to vasodilator substances, normal endothelial release of NO also results in a lower dilator response, thus leading to an erroneous diagnosis of impaired endotheliumdependent dilatation. Ischaemic Heart Disease, Stroke and Risk Factors
On the other hand, the increase in CBF determined by direct arteriolar vasodilators may also depend on endothelium-dependent, flow-mediated pre-arteriolar dilatation, and adenosine, in particular, may in part also act through endothelial NO release. 43 Thus, in most cases it is not possible to attribute CMD with certainty to only one of the specific mechanisms that can be responsible for its occurrence. 
Microvascular Angina Versus Stable Angina
Diagnosis of primary stable MVA presupposes a lack of obstructive CAD in patients with a stable pattern of chest pain. Importantly, while until a few years ago this could be achieved only by invasive coronary angiography, the documentation of normal (or near-normal) coronary arteries can now reliably be obtained by non-invasive angio-CT scan.
Accordingly, in clinical practice, a non-invasive CT coronary angiography can be recommended to define the coronary picture in symptomatic patients with a high probability of MVA. This would avoid the small risk as well as higher costs related to a more invasive procedure. As suggested above, the documentation of CMD to support the diagnosis of MVA may in these cases be achieved by non-invasive methods (see above). 
Diagnostic for Stable Angina and No Obstructive Coronary Arteries
E U R O P E A N C A R D I O L O G Y R E V I E W
Advanced Imaging Stress Tests
Stress tests with PET, CMR or myocardial contrast echocardiography can be used to detect abnormalities in myocardial perfusion and ischaemia, but may present similar issues as those described for myocardial scintigraphy. As discussed above, these methods can instead be significant for the assessment of CMD in NO-CAD patients.
Diagnostic Algorithm Invasive coronary angiography, on the other hand, should be directly recommended in angina patients with only a low-to-moderate probability of MVA. Provocative tests should only be performed during the invasive diagnostic procedure in case of detection of normal or near-normal coronary arteries.
Whether careful characterisation of functional abnormalities of coronary circulation (and CMD in particular) by this approach will impact the therapeutic management of patients needs to be ascertained in adequately designed randomised studies.
